217 related articles for article (PubMed ID: 10701023)
21. Gout, bradycardia, and hypercholesterolemia after renal transplantation.
Kelleher SP; Davis WR; Paraskevopoulos N
South Med J; 2001 Jul; 94(7):732-4. PubMed ID: 11531183
[TBL] [Abstract][Full Text] [Related]
22. [Aspects of colchicine therapy. 1: Pharmacology, toxicology, classic indications].
Lange U; Schumann C; Schmidt KL
Z Arztl Fortbild Qualitatssich; 2002 Jan; 96(1):59-63. PubMed ID: 11876051
[TBL] [Abstract][Full Text] [Related]
23. Colchicine prescribing in patients with gout.
Dalbeth N; Gow P;
N Z Med J; 2011 Jul; 124(1339):107-8. PubMed ID: 21952339
[No Abstract] [Full Text] [Related]
24. Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomised trial?
Giannopoulos G; Deftereos S
Ann Rheum Dis; 2016 May; 75(5):e28. PubMed ID: 26893488
[No Abstract] [Full Text] [Related]
25. Colchicine--what is its place in the management of acute gout?
Winzenberg T; Zochling J
Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668
[TBL] [Abstract][Full Text] [Related]
26. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: the effect of index date selection?
Nielen JT; Oshagbemi O; de Vries F; Burden AM
Ann Rheum Dis; 2016 May; 75(5):e26. PubMed ID: 26873268
[No Abstract] [Full Text] [Related]
27. Treatment of acute gout.
Schlesinger N
Rheum Dis Clin North Am; 2014 May; 40(2):329-41. PubMed ID: 24703350
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.
Wechalekar MD; Vinik O; Moi JH; Sivera F; van Echteld IA; van Durme C; Falzon L; Bombardier C; Carmona L; Aletaha D; Landewé RB; van der Heijde DM; Buchbinder R
J Rheumatol Suppl; 2014 Sep; 92():15-25. PubMed ID: 25180124
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of hyperuricemia and gout].
Pöllmann G; Kullich W; Klein G
Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
[TBL] [Abstract][Full Text] [Related]
30. Update on colchicine, 2017.
Slobodnick A; Shah B; Krasnokutsky S; Pillinger MH
Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i4-i11. PubMed ID: 29272515
[TBL] [Abstract][Full Text] [Related]
31. Colchicine prescribing and safety monitoring in patients with gout.
Ly J; Gow P; Dalbeth N
N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
[TBL] [Abstract][Full Text] [Related]
32. Update on colchicine and its mechanism of action.
Molad Y
Curr Rheumatol Rep; 2002 Jun; 4(3):252-6. PubMed ID: 12010611
[TBL] [Abstract][Full Text] [Related]
33. Discussion following cases 4 and 5.
Croft JD
Am J Med; 2006 Nov; 119(11 Suppl 1):S16-9. PubMed ID: 17059906
[No Abstract] [Full Text] [Related]
34. Risks and benefits of drugs used in the management and prevention of gout.
Conaghan PG; Day RO
Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
[TBL] [Abstract][Full Text] [Related]
35. Deaths associated with inappropriate intravenous colchicine administration.
Bonnel RA; Villalba ML; Karwoski CB; Beitz J
J Emerg Med; 2002 May; 22(4):385-7. PubMed ID: 12113850
[TBL] [Abstract][Full Text] [Related]
36. Response to: 'Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?' by Giannopoulos and Deftereos.
Solomon DH; Kim SC
Ann Rheum Dis; 2016 May; 75(5):e29. PubMed ID: 26929220
[No Abstract] [Full Text] [Related]
37. Treatment of acute gout in hospitalized patients.
Petersel D; Schlesinger N
J Rheumatol; 2007 Jul; 34(7):1566-8. PubMed ID: 17610315
[TBL] [Abstract][Full Text] [Related]
38. Is Remission a Valid Target for Gout?
Pascual E; Andrés M; Sivera F
J Rheumatol; 2020 Jan; 47(1):4-5. PubMed ID: 31894090
[No Abstract] [Full Text] [Related]
39. An evidence based appraisal of the management of nontophaceous interval gout.
Ferraz MB
J Rheumatol; 1995 Sep; 22(9):1618-9. PubMed ID: 8523332
[No Abstract] [Full Text] [Related]
40. Should prednisolone be first-line therapy for acute gout?
Richette P; Bardin T
Lancet; 2008 Oct; 372(9646):1301; author reply 1301-2. PubMed ID: 18929902
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
